Recombinant EGFR (Serclutamab Biosimilar) antibody

Catalog No. ABIN7488206

The Mammalian Cells Monoclonal anti-EGFR (Serclutamab Biosimilar) antibody is suitable to detect EGFR (Serclutamab Biosimilar) in samples from Human. It has been validated for ELISA.

Quick Overview for Recombinant EGFR (Serclutamab Biosimilar) antibody (ABIN7488206)

Target: EGFR (Serclutamab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This EGFR (Serclutamab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-EGFR (Serclutamab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Serclutamab Biosimilar - Anti-EGFR mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for EGFR (Serclutamab Biosimilar)

Target: EGFR (Serclutamab Biosimilar)

Target Type: Biosimilar

Background: DC-1630423,PR-1594407
Serclutamab is a biosimilar that targets EGFR.

CAS-No: 2140172-41-2